Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19

OBJECTIVES: Intracerebral hemorrhage/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported. CASE PRESENTATION: A 86yo Caucasian female suddenly developed aphasia with a systolic blood pressure of 220 mmHg. Cerebral imag...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Scorza, Fulvio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256660/
https://www.ncbi.nlm.nih.gov/pubmed/34250455
http://dx.doi.org/10.1016/j.hest.2021.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256660/
https://www.ncbi.nlm.nih.gov/pubmed/34250455
http://dx.doi.org/10.1016/j.hest.2021.06.005

Ejemplares similares